Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Positive interim data from phase II study of Allocetra in severe and critical COVID-19

Dec. 4, 2020

Deglycosylated receptor-binding domain recombinant proteins as scalable SARS-CoV candidates

Dec. 4, 2020

CARB-X awards funding to German institutions

Dec. 3, 2020

Tc24-C4.10E shows promise for the treatment of Chagas disease

Dec. 3, 2020

Appili initiates new phase III trial of Avigan for treatment of COVID-19

Dec. 3, 2020

Environmental support helps blood stem cells cope

Dec. 3, 2020

Cel-Sci reports preclinical data on LEAPS COV-19 peptides

Dec. 3, 2020

U.K. approval for Pfizer and BioNTech's COVID-19 mRNA vaccine BNT-162b2

Dec. 2, 2020

FDA clears IND for phase I study of DHOHD inhibitor RP-7214 for COVID-19

Dec. 2, 2020

DMC completes positive safety review of CYNKCOVID study

Dec. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...